期刊文献+

异种移植免疫学研究进展 被引量:4

THE ADVANCES IN IMMUNOLOGICAL RESEARCH ON XENOTRANSPLANTATION
暂未订购
导出
摘要 目的 论述异种移植排斥反应的发生机制和各种免疫细胞的相互作用。方法 结合基础研究相关资料对异种移植免疫学研究成果和新进展作一回顾。结果 转基因猪技术 ,新型免疫抑制剂等分别用以克服超急性排斥 ,急性血管性排斥 ;急性细胞性排斥的克服采用了针对 T细胞、抗原递呈细胞的策略以及诱导免疫耐受等方法。结论 转基因猪技术较为成熟而有效 ;急性血管性排斥 ,急性细胞性排斥的发生机制和克服仍有待进一步研究。 Objective To investigate the mechanism of xenotransplantation rejection and the interaction between the immunocytes. Methods This review concluded the research achievements and new advances in xeno transplantation based on the relevant experimental data. Results Transgenic pig technology and novel immunosuppressants were applied to suppress hyperacute rejection and acute vascular rejection respectively. Modulation of T cell and antigen presenting cells and induction of tolerance were taken for the prevention of acute cellular rejection. Conclusion In general, the technology of transgenic pig is relatively mature and effective. The mechanism and prevention of acute vascular rejection and acute cellular rejection should be further investigated.
作者 冯莉 李幼平
出处 《中国修复重建外科杂志》 CAS CSCD 2002年第4期284-287,共4页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目 (39993430 )
关键词 异种移植 移植免疫 排斥反应 Xenotransplantation Transplantation immunology Rejection
  • 相关文献

参考文献2

二级参考文献13

共引文献24

同被引文献84

  • 1Gock HM, Cowan PD, Apice JF. Leukocyte recruitment in xenotransplantation [ J ]. Organ Transplant, 2002, 7 (1) :85-91.
  • 2Kellersmann R, Kellersmann A, Thiede A, et al. Comparison of in vivo lymphocyte proliferation between allogeneic and xenogeneic heart transplantation in mice [ J ]. Microsurgery, 2003,23:498.
  • 3Ashton - chess J, Roussel JC, Manez R, et al. Cellular participation in delayed xenograft rejection of hcd55 transgenic pig hearts by baboons [J]. Xenotransplantation,2003,10:446.
  • 4Lin SS, Kooyman DL, Daniels LJ, et al. The role of natural anti-Gal alpha 1-3Gal antibodies in hyperacute rejection of pig-to-banboo cardiac xenotransplants. Transpl Immunol, 1997,5(3):212-218.
  • 5Sasaki H, Xu XC, Smith DM, et al. HLA-G expression protects porcine endothelial cells against natural killer cell-mediated xenogeneic cytotoxicity. Transplantation, 1999,67(1):31-37.
  • 6Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc, 2001,33(3): 2355-2359.
  • 7Loke YW, King A. Immunology of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol, 2000,14(5): 827-837.
  • 8Hiby SE, King A, Sharkey AM, et al. Human uterine NK cells have a similar repertoire of killer inhibitory and activatory receptors to those found in blood, as demonstrated by RT-PCR and sequencing. Mol Immunol, 1997, 34(5):419-430.
  • 9Chumbley G, King A, Robertson K, et al. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol , 1994,155(2):312-322.
  • 10Forte P, Pazmany L, Matter-Reissmann UB, et al. HLA-G inhibits rolling adhesion of activated human NK cells on porcine endothelial cells. J Immunol, 2001, 167(10): 6002-6008.

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部